Dec 6, 2000|
FMCG: Under a microscope
The FMCG (fast moving consumer goods) companies seem back in the reckoning. The bourses are looking at these so-called defensive stocks for refuge as the NASDAQ blues have also watered down to our ‘desi’ TMT stocks. Let’s look at the valuations of some leading FMCG companies and see what they have to offer.
The valuation matrix
||911 / 468
||685 / 408
||241 / 136
||310 / 169
||1028 / 515
||548 / 292
||842 / 533
||355 / 189
||645 / 315
||599 / 169
|*calculated on FY02 estimated earnings
The above table reflects the relative valuations of some of the top companies and offers different opportunities in each of them. Some however, are better than the others. Cadbury stands at the top of the heap as per the current P/e valuations. But this is largely a function of the future growth rates the company is going to achieve. The company profits are expected to grow at a CAGR (compounded annual growth rate) of 54% till FY02. At the current price of Rs 563, the stock trades at a hefty 65 times its FY00 earnings, but if you were to buy the stock at this price today, the based on our estimates for FY02, the stock trades at a reasonable 32 times its FY02 estimated earnings.
Similarly, though Tata Tea looks attractive at a P/e multiple of 9.4 times its FY00 earnings, but even by FY02 standards, the P/e multiple is more or less the same. This is as a result of an expected stagnancy in its profits even in FY02. But based on book value, the Tata Tea stock looks undervalued.
But the companies to look out for at the current valuations are FMCG giant Hindustan Lever, Smithkline Beecham Consumer and Reckitt and Colman. Hindustan Lever’s sheer size and scale of operations makes it a company to watch out for. At a P/e multiple of 38 times its FY00 earnings, the stock offers a good entry opportunity. The current valuations, which the stock is receiving, are a result of the company not doing too well in the rural areas this year. Drought situations in certain states of the country have affected growth. However, all this is factored into the current price. The likely triggers for the future could be a good monsoon and acquisitions (which the company is historically famous for).
For Smithkline Consumer, there are concerns regarding the company’s future partner or owner in India. But the company’s product profile is a winner. Whoever, buys it over (whether HLL, Nestle or Cadbury), this will be a win-win situation for all. A P/e multiple of 12 times based on its FY02 estimated earnings, looks attractive considering the ‘Horlicks’ brand name and positioning.
The household cleaning major, Reckitt and Colman is a very focused company. Based on its projected FY02 earnings, the company will trade at 28 times, which looks encouraging. However, the only concern for this company should come in the wake of rising competition and its ability to stay and penetrate the market.
All in all, the sector shows immense potential and hence, is definitely worth a look.
More Views on News
Aug 9, 2017
While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.
Dec 9, 2016
Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
Nov 30, 2016
Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.
Nov 30, 2016
GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.
Nov 28, 2016
Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407